Asceneuron
Targeting Tau
Eysins, Switzerland · Founded 2012 · $130.0M raised
- Headquarters
- Eysins
- Employees
- 11–50
- Founded
- 2012
- Business Model
- B2B
- Website
- asceneuron.com
- Total Funding
- $130.0M
- Last Round
- $100.0M Series CJul 2024
- Rounds
- 2
About
Asceneuron is a clinical-stage biopharmaceutical company focused on discovering and developing orally bioavailable small molecule therapeutics for neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, and orphan tauopathies. The company's lead program, ASN51, targets tau pathology — a hallmark of multiple neurodegeneration diseases — and advanced into Phase 2 clinical trials following a $100 million Series C financing in 2024. Asceneuron is headquartered in Eysins, Switzerland and is backed by EQT Life Sciences and Sofinnova Partners.
Summary
Asceneuron is a Biotech company based in Eysins, Switzerland, founded in 2012. It has raised $130.0M in total across 2 rounds, most recently a $100.0M Series C round in Jul 2024. Investors include Sofinnova Partners, Novo Holdings A/S and SR One.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2024
Sign up to see all 2 rounds
Series A through Series C — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/asceneuron"><img src="https://indexed.vc/api/badge/company/asceneuron" alt="Asceneuron on Indexed.vc" width="260" height="76" /></a>